Results 221 to 230 of about 45,454 (280)

Incidence of Cholangitis in Post‐Endoscopic Retrograde Cholangiopancreatography (ERCP): A Systematic Review and Meta‐Analysis

open access: yesJGH Open, Volume 10, Issue 3, March 2026.
ABSTRACT Background Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure that combines x‐ray and upper gastrointestinal (GI) endoscopy for diagnosis and treatment of pancreatic and biliary diseases. Cholangitis is the main infectious complication after ERCP surgery.
Shiwen Huang   +6 more
wiley   +1 more source

Brazilian Society of Surgical Oncology: Guidelines and Consensus Statement for Palliative Surgery in Oncology

open access: yesJournal of Surgical Oncology, Volume 133, Issue 4, Page 421-432, March 15, 2026.
ABSTRACT Background and Objective Palliative surgery in oncology aims to relieve symptoms, improve quality of life, and respect patient autonomy in advanced cancer. This study aimed to develop evidence‐based recommendations for safely indicating and performing palliative surgeries in Brazil, considering clinical, ethical, and multidisciplinary aspects.
Audrey Cabral Ferreira de Oliveira   +15 more
wiley   +1 more source

Effectiveness and Safety of Enteroscopy‐Assisted ERP‐Guided Versus EUS‐Guided Pancreatic Duct Drainage for Pancreaticojejunostomy Strictures: A Multicenter Observational Study

open access: yesDigestive Endoscopy, Volume 38, Issue 3, March 2026.
Comparative effectiveness and safety of eERP‐PDD versus EUS‐PDD for pancreaticojejunostomy strictures: EUS‐PDD demonstrated higher technical and clinical success with comparable safety after adjustment, and an MPD diameter–based treatment algorithm is proposed.
Shogo Ota   +24 more
wiley   +1 more source

Toward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers

open access: yesJournal of Gastroenterology and Hepatology, Volume 41, Issue 3, Page 895-913, March 2026.
ABSTRACT Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive cancers, typically diagnosed at an advanced stage due to its subtle and often absent early symptoms. Despite representing only 3% of new cancer cases, it is projected to become the second leading cause of cancer‐related deaths by 2030.
Muhammad Masroor Hussain   +5 more
wiley   +1 more source

Unraveling the Complications: Stent Migration and Duodenal Fistula in a Metastatic Desmoplastic Round Cell Tumor. [PDF]

open access: yesACG Case Rep J
Cymbal M   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy